Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a promising biomarker for prognosis of high grade T1 bladder cancer

Int Urol Nephrol. 2024 Apr 2. doi: 10.1007/s11255-024-04035-3. Online ahead of print.

Rui M Bernardino^{1

2}, Marian Wettstein³, Juan Garisto⁴, Neil E Fleshner³

¹ Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, 700 University Avenue, Toronto, ON, Canada. ruimmbernardino@gmail.com.
² Computational and Experimental Biology Group, Faculdade de Ciências Médicas, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal. ruimmbernardino@gmail.com.
³ Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, 700 University Avenue, Toronto, ON, Canada.
⁴ Weill Cornell Medicine Urology, NewYork-Presbyterian Hospital, NewYork, NY, USA.

No abstract available

Publication types